Embattled Alzheimer’s Researcher Is Charged With Fraud NYT: Science By: Apoorva Mandavilli 28 June 2024 at 18:05 Hoau-Yan Wang, a professor at City College, published studies supporting simufilam, now in advanced clinical trials. © Ilana Panich-Linsman for The New York TimesHoau-Yan Wang’s work underpinned research into a diagnostic test for Alzheimer’s disease and simufilam, a drug in advanced clinical trials made by Cassava Sciences in Austin, Texas.
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly NYT: Science By: Gina Kolata and Pam Belluck 10 June 2024 at 17:05 The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.
Alzheimer’s Takes a Financial Toll Long Before Diagnosis, Study Finds NYT: Science By: Ben Casselman 31 May 2024 at 11:13 New research shows that people who develop dementia often begin falling behind on bills years earlier. © Krisanapong Detraphiphat/Getty Images
Login
